# Primary Mediastinal Malignant Melanoma Presenting With Pleural Effusion: A Case Report

**Authors:** Minlian Nong, Weifeng Wei, Naijian Li, Yunxiang Zeng, Jinlin Wang

PMC · DOI: 10.1002/cnr2.70484 · Cancer Reports · 2026-02-02

## TL;DR

A rare case of primary mediastinal melanoma initially showed as pleural effusion, highlighting the need for early diagnosis and intervention.

## Contribution

Reports a rare case of PMMM presenting with pleural effusion and emphasizes the importance of pathological diagnosis.

## Key findings

- PMMM can present with pleural effusion as the initial symptom, making diagnosis challenging.
- Pleural hemorrhage may be a characteristic feature of pleural metastasis in PMMM.
- Prognosis for PMMM with pleural effusion is poor despite temporary interventions.

## Abstract

Primary mediastinal malignant melanoma (PMMM) presenting with pleural effusion as the initial manifestation is exceedingly rare, presenting significant diagnostic and therapeutic challenges. This article reports a case of PMMM that initially manifested as pleural effusion and includes a review of the relevant literature.

The patient was admitted with pleural effusion and an anterior mediastinal mass. A pleural biopsy and fine‐needle aspiration of the mediastinal mass led to a pathological diagnosis of malignant melanoma. Ultimately, based on clinical findings, a final diagnosis of PMMM was established. The patient subsequently developed pleural hemorrhage; although hemostasis was achieved through thoracoscopy, his condition stabilized only temporarily. He ultimately succumbed to lung infection and multiple organ failure.

PMMM presenting with pleural effusion lacks distinct clinical features, highlighting the importance of pathological diagnosis. Pleural hemorrhage associated with pleural metastasis may be a characteristic feature, and the prognosis for such cases is poor. Enhanced recognition and early intervention are essential to improve outcomes.

## Linked entities

- **Diseases:** malignant melanoma (MONDO:0005105), multiple organ failure (MONDO:0043726)

## Full-text entities

- **Genes:** ERG (ETS transcription factor ERG) [NCBI Gene 2078] {aka LMPHM14, erg-3, p55}, MAP2K7 (mitogen-activated protein kinase kinase 7) [NCBI Gene 5609] {aka JNKK2, MAPKK7, MEK, MEK 7, MKK7, PRKMK7}, ENO2 (enolase 2) [NCBI Gene 2026] {aka HEL-S-279, NSE}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, S100A1 (S100 calcium binding protein A1) [NCBI Gene 6271] {aka S100, S100-alpha, S100A}, ADA (adenosine deaminase) [NCBI Gene 100] {aka ADA1}, BRAF (B-Raf proto-oncogene, serine/threonine kinase) [NCBI Gene 673] {aka B-RAF1, B-raf, BRAF-1, BRAF1, NS7, RAFB1}, MUC16 (mucin 16, cell surface associated) [NCBI Gene 94025] {aka CA125}, CEACAM3 (CEA cell adhesion molecule 3) [NCBI Gene 1084] {aka CD66D, CEA, CGM1, CGM1a, W264, W282}, CMPK1 (cytidine/uridine monophosphate kinase 1) [NCBI Gene 51727] {aka CK, CMK, CMPK, UMK, UMP-CMPK, UMPK}, SALL4 (spalt like transcription factor 4) [NCBI Gene 57167] {aka DRRS, HSAL4, IVIC, ZNF797}
- **Diseases:** Respiratory Diseases (MESH:D012140), cough (MESH:D003371), esophageal or pulmonary (MESH:D004941), Cardiovascular and Cerebrovascular Diseases (MESH:D002318), amelanotic melanoma (MESH:D018328), metastasis (MESH:D009362), wheezing (MESH:D012135), lung infection (MESH:D012141), melanocytic lesions (MESH:D009508), inflammatory (MESH:D007249), septic shock (MESH:D012772), Metabolic Diseases (MESH:D008659), effusions (MESH:D000080324), anterior mediastinal mass (MESH:D008480), Pleural Effusion (MESH:D010996), Pleural hemorrhage (MESH:D010995), fever (MESH:D005334), fungal (MESH:D009181), necrosis (MESH:D009336), respiratory distress (MESH:D012128), non-small cell lung cancer (MESH:D002289), dyspnea (MESH:D004417), anemia (MESH:D000740), malignant pleural effusion (MESH:D016066), infection (MESH:D007239), cutaneous malignant melanoma (MESH:C562393), acute kidney injury (MESH:D058186), tuberculosis (MESH:D014376), bleeding (MESH:D006470), malignancy (MESH:D009369), hyperkalemia (MESH:D006947), sepsis (MESH:D018805), metabolic acidosis (MESH:D000138), multi-organ failure (MESH:D009102), coagulation (MESH:D001778), TB (MESH:D014390), Lung tumor (MESH:D008175), anterior (MESH:D020759), Primary Mediastinal Malignant Melanoma (MESH:D008545)
- **Chemicals:** dabrafenib (MESH:C561627), HE (MESH:D006371), ipilimumab (MESH:D000074324), glucose (MESH:D005947), nivolumab (MESH:D000077594), pembrolizumab (MESH:C582435), bevacizumab (MESH:D000068258)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** V600E

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12863993/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12863993/full.md

## References

17 references — full list in the complete paper: https://tomesphere.com/paper/PMC12863993/full.md

---
Source: https://tomesphere.com/paper/PMC12863993